BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 164644)

  • 21. Human chorionic gonadotropin and its subunits in hydatidiform mole and choriocarcinoma.
    Dawood MY; Saxena BB; Landesman R
    Obstet Gynecol; 1977 Aug; 50(2):172-81. PubMed ID: 195242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis and treatment of trophoblastic disease. A report from the Southeastern Regional Center.
    Hammond CB; Parker RT
    Obstet Gynecol; 1970 Jan; 35(1):132-43. PubMed ID: 4311884
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
    Zhang WY
    Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistent low-level "real" human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma.
    Kohorn EI
    Gynecol Oncol; 2002 May; 85(2):315-20. PubMed ID: 11972394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radioimmunoassay of the beta-subunit of human chorionic gonadotropin, monitor of chemotherapy in gestational trophoblastic neoplasm.
    Jones WB; Lehr M; Lewis JL
    Surg Forum; 1973; 24():563-5. PubMed ID: 4377042
    [No Abstract]   [Full Text] [Related]  

  • 26. [Detection of hCG production in trophoblastic diseases by HCG beta carboxyl-terminal peptide].
    Shimizu T; Matsuura S; Mochizuki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Oct; 35(10):1759-66. PubMed ID: 6195275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring therapy in trophoblastic diseases by radioimmunoassay of pregnancy-specific beta 1-glycoprotein and the beta subunit of human chorionic gonadotropin.
    Than GN; Csaba IF; Bohn H; Szabó DG; Szalmásy M; Menczer G
    Oncodev Biol Med; 1982; 3(4):315-23. PubMed ID: 6291007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The hCG assay in the treatment of trophoblastic disease.
    Pattillo RA; Hussa RO
    J Reprod Med; 1984 Nov; 29(11):802-12. PubMed ID: 6097684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia among women with partial molar pregnancies.
    Growdon WB; Wolfberg AJ; Feltmate CM; Goldstein DP; Genest DR; Chinchilla ME; Berkowitz RS; Lieberman ES
    J Reprod Med; 2006 Nov; 51(11):871-4. PubMed ID: 17165432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum progesterone monitoring in post-molar surveillance.
    Vasilev SA; Schlaerth JB; Ahn C; Sauer MV
    Gynecol Oncol; 1994 Sep; 54(3):288-91. PubMed ID: 7522199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral contraceptives and postmolar trophoblastic disease.
    Berkowitz RS; Goldstein DP; Marean AR; Bernstein M
    Obstet Gynecol; 1981 Oct; 58(4):474-7. PubMed ID: 6269038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedent pregnancy.
    Chen RJ; Huang SC; Chow SN; Hsieh CY; Hsu HC
    Br J Obstet Gynaecol; 1994 Apr; 101(4):330-4. PubMed ID: 8199080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma prolactin, progesterone, estradiol, and human chorionic gonadotropin in complete and partial moles before and after evacuation.
    Ho PC; Wong LC; Ma HK
    Obstet Gynecol; 1986 Jan; 67(1):99-106. PubMed ID: 3940346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gestational Trophoblastic Neoplasia After Human Chorionic Gonadotropin Normalization Following Molar Pregnancy: A Systematic Review and Meta-analysis.
    Albright BB; Shorter JM; Mastroyannis SA; Ko EM; Schreiber CA; Sonalkar S
    Obstet Gynecol; 2020 Jan; 135(1):12-23. PubMed ID: 31809433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of gestational trophoblastic disease by use of actinomycin D in molar pregnancies.
    Goldstein DP
    Obstet Gynecol; 1974 Apr; 43(4):475-9. PubMed ID: 4361440
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical features of early-stage nonhydropic mole for diagnosis of persistent trophoblastic disease.
    Miyoshi J; Ohba T; Fukunaga M; Katabuchi H
    Obstet Gynecol; 2011 Oct; 118(4):847-53. PubMed ID: 21934448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY; Yen GL
    Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical therapy for gestational trophoblastic disease.
    Soper JT
    J Reprod Med; 1994 Mar; 39(3):168-74. PubMed ID: 8035372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease].
    Delpont PJ; Ruf H; Blanc B; Gamerre M; Adrai J; Conte M; Dupont S; Bellia-Rousseau J
    Rev Fr Gynecol Obstet; 1985 Oct; 80(10):737-52. PubMed ID: 2417299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of persistent gestational trophobalstic neoplasia: the role of hCG level and ratio in 2 weeks after evacuation of complete mole.
    Kang WD; Choi HS; Kim SM
    Gynecol Oncol; 2012 Feb; 124(2):250-3. PubMed ID: 22094931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.